September 2026 Br J Cardiol 2026;33:95–101 doi:10.5837/bjc.2026.041
Rosie Oatham, Kiana Mostaghimi, Lydia Bevis, Milos Prica, David Warriner
Introduction As outlined by Prica et al.,1 the number of children with congenital heart disease (CHD) surviving to, and thriving in, adulthood has increased dramatically since the 1980s due to earlier diagnosis and advances in transcatheter and surgical techniques. Consequently, the adult congenital heart disease (ACHD) population is larger than ever, and many patients will present to non-ACHD specialists with a variety of medical problems, cardiac or otherwise. Therefore, a working understanding of these lesions is key for all front-line physicians. However, ACHD remains a highly specialised subject with limited evidence-base. This review ar
May 2012 Br J Cardiol 2012;19:58
BJCardio Staff
This image of Tetralogy of Fallot has won Carol Young, a radiographer at Great Ormond Street Hospital, London, an award for the best image quality and lowest radiation dose in the Siemens Healthcare International CT Image Contest. She beat 627 other entries from 43 countries Sitagliptin licence in renal disease Sitagliptin (Januvia®, MSD) has received a licence in the UK for use in people with type 2 diabetes with moderate to severe renal impairment. The licence follows data from two clinical studies. In one study comparing sitagliptin (25 mg or 50 mg once daily) with glipizide (2.5 to 20 mg once daily) in patients with type 2 diabetes and
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits